Unilateral Breast Carcinoma
|
2
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Unilateral Breast Neoplasms
|
2
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
24
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2017 |
2017 |
Intestinal metaplasia
|
24
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
|
1 |
2013 |
2013 |
Malaria, Cerebral
|
34
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2019 |
2019 |
Adult Diffuse Large B-Cell Lymphoma
|
46
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2020 |
2020 |
Sporadic Breast Carcinoma
|
46
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2013 |
2013 |
Stomach Neoplasms
|
55
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.020 |
0.500 |
2 |
2019 |
2020 |
Gastritis, Atrophic
|
61
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2017 |
2017 |
Secondary Neoplasm
|
85
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2015 |
2015 |
Breast Cancer, Familial
|
91
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2010 |
2010 |
Atrial Septal Defects
|
96
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Diffuse Large B-Cell Lymphoma
|
127
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2020 |
2020 |
HIV Infections
|
142
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
|
1 |
2016 |
2016 |
Tumor Cell Invasion
|
169
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Secondary malignant neoplasm of lymph node
|
188
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Malignant neoplasm of esophagus
|
214
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
|
1 |
2017 |
2017 |
Malignant tumor of cervix
|
245
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
cervical cancer
|
268
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Esophageal Neoplasms
|
270
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
|
1 |
2017 |
2017 |
Esophageal carcinoma
|
272
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
|
1 |
2017 |
2017 |
Cervix carcinoma
|
283
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Renal Cell Carcinoma
|
288
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2012 |
2012 |
Neoplasm Metastasis
|
327
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2015 |
2015 |
Carcinogenesis
|
355
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
0.667 |
3 |
2012 |
2019 |